This is the authors' abstract. We don't add key points for this paper.
Interview with Dr. Raymond Chung on the science behind evolving treatments for hepatitis C and progress toward a cure. (16:14)Download The development of direct-acting antiviral agents has revolutionized the treatment of hepatitis C by offering genuine prospects for a comprehensive cure of a chronic viral infection. This success can be traced to important scientific, clinical, and regulatory developments.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: